Study finds a surprising new role for a major immune regulator
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
The program supports early-career faculty who have strong potential to become leaders in their fields and to advance diversity, equity, and inclusion.
Alex Shalek’s technologies for single-cell RNA profiling can help dissect the cellular bases of complex diseases around the globe.
The targeted approach eliminated tumors in mice, with minimal side effects.
The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases.
Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection.
Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response.
Ragon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development.
Enlisted in the fight against HIV, MIT engineers and scientists contribute new technology, materials and computational studies.
New technology could help AIDS researchers develop new vaccines.